Featured
· ECCMID 2021, Vienna
At the 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID, www.eccmid.org), Pataigin introduced the BACLIB Rapid Lipid Extraction Kit for microbial identification and colistin resistance detection.
SEATTLE, WA – 30 March, 2026 – Microbiology diagnostics company Pataigin today appointed Michael Chen as Medical Director to facilitate implementation of BACLIB in the clinical diagnostic …
SEATTLE, WA – 30 March, 2022 – Microbiology diagnostics company Pataigin today appointed Deborah A. Elvins as an advisor to the company on business strategy and other business matters.
LISBON, Portugal: Results will be presented from a study of Pataigin’s rapid bacterial ID assay, direct from clinical specimens.
Today, the US NIH awarded Pataigin a research grant to further development of Pataigin’s Rigel antimicrobial susceptibility test.
Today, Pataigin founder Prof. Robert Ernst presented results of a new assay that determines microbial ID and colistin resistance in one hour, direct from clinical specimens. The assay uses …